Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy
Authors
Keywords
-
Journal
Cancers
Volume 7, Issue 4, Pages 2360-2371
Publisher
MDPI AG
Online
2015-12-04
DOI
10.3390/cancers7040897
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π–Π Stacking Stabilized Polymeric Micelles
- (2015) Yang Shi et al. ACS Nano
- Multiple Drug Transport Pathways through Human P-Glycoprotein
- (2015) James W. McCormick et al. BIOCHEMISTRY
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- Pharmacologic Sensitivity of Paclitaxel to Its Delivery Vehicles Drives Distinct Clinical Outcomes of Paclitaxel Formulations
- (2015) Yan Li et al. MOLECULAR PHARMACEUTICS
- Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics
- (2015) Stefan Vallo et al. Translational Oncology
- The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study
- (2015) Rishil J. Kathawala et al. Oncotarget
- Nature as a remarkable chemist
- (2014) Mansukh C. Wani et al. ANTI-CANCER DRUGS
- Masitinib Antagonizes ATP-Binding Cassette Subfamily C Member 10-Mediated Paclitaxel Resistance: A Preclinical Study
- (2014) R. J. Kathawala et al. MOLECULAR CANCER THERAPEUTICS
- Extracellular stability of nanoparticulate drug carriers
- (2013) Karen C. Liu et al. ARCHIVES OF PHARMACAL RESEARCH
- Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10)
- (2013) WEN DENG et al. ONCOLOGY REPORTS
- Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs
- (2013) Rishil J. Kathawala et al. Chinese Journal of Cancer
- Reversing multidrug resistance by tyrosine kinase inhibitors
- (2012) Miao He et al. Chinese Journal of Cancer
- New insights into mechanisms of resistance to microtubule inhibitors
- (2011) Anutosh Ganguly et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10-/- Mice
- (2011) E. A. Hopper-Borge et al. CANCER RESEARCH
- Mitotic Centromere-associated Kinesin (MCAK) Mediates Paclitaxel Resistance
- (2011) Anutosh Ganguly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of Mitotic Centromere-Associated Kinesin Stimulates Microtubule Detachment and Confers Resistance to Paclitaxel
- (2011) A. Ganguly et al. MOLECULAR CANCER THERAPEUTICS
- Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer
- (2011) Daniele Vergara et al. Nanomedicine-Nanotechnology Biology and Medicine
- Multidrug resistance associated proteins in multidrug resistance
- (2011) Kamlesh Sodani et al. Chinese Journal of Cancer
- A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer
- (2010) R. J. Kelly et al. CLINICAL CANCER RESEARCH
- Influence of Cremophor EL and Genetic Polymorphisms on the Pharmacokinetics of Paclitaxel and Its Metabolites Using a Mechanism-Based Model
- (2010) M. N. Fransson et al. DRUG METABOLISM AND DISPOSITION
- Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
- (2010) A. Ganguly et al. MOLECULAR CANCER THERAPEUTICS
- Molecular Basis for Class V β-Tubulin Effects on Microtubule Assembly and Paclitaxel Resistance
- (2009) Rajat Bhattacharya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer
- (2008) Catherine Lhommé et al. JOURNAL OF CLINICAL ONCOLOGY
- MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer
- (2008) T. Oguri et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started